Ugandan town at the heart of Bundibugyo District
A Bundibugyo-strain Ebola outbreak has produced more than 500 confirmed cases across eastern Democratic Republic of Congo and at least 19 confirmed cases in Uganda. WHO has declared a public health emergency of international concern; authorities are scaling up testing, treatment centres and cross-border preparedness while contact tracing and supplies remain insufficient.
Eastern Congo faces one of the fastest Ebola outbreaks on record. The Bundibugyo strain has no approved vaccine or treatment. Health workers describe chronic PPE shortages and rising infections. Women, who are the primary caregivers at home, face heightened risk and fear as frontline staff struggle to manage the outbreak.
The Ebola outbreak in eastern Congo is being driven by the Bundibugyo virus. It has declared a public health emergency; more than 550 cases have been confirmed, with 101 deaths and 19 recoveries. Health workers face attacks, local scepticism, and armed conflict that hinder containment. Cases are concentrated in Ituri, with spread to North Kivu and South Kivu and across the border into Uganda. Vaccines and treatments remain unavailable for this strain.
A Bundibugyo Ebola outbreak is driving rapid development of vaccines and antibody therapies. Doses of MBP134 are being used for compassionate use and clinical trials, while several vaccine candidates are advancing toward human testing. Trials face challenges from battlefield-like conditions in eastern Congo and Uganda.
Health workers are facing a worsening Ebola outbreak in eastern Congo, with Ituri accounting for the majority of cases. Attacks on clinics and burial teams have disrupted containment efforts, while Bundibugyo strain shows no approved treatment or vaccine. Hundreds have been infected and deaths exceed two hundred as authorities warn of a growing regional risk.
Health authorities have reported at least 1,759 confirmed Ebola cases and about 600 deaths in the Democratic Republic of Congo since mid-May, driven by the rare Bundibugyo strain. The World Health Organization has enrolled the first patient in a trial testing MBP134 and remdesivir; treatment centres are strained and insecurity and funding shortfalls are hindering response.
The Bundibugyo-strain Ebola outbreak in the DR Congo has intensified, with cases rising and deaths increasing. Health workers are striking over unpaid salaries, while international partners warn the official figures may undercount the true toll. Trials for treatments have begun, and vaccination efforts remain limited by the absence of a vaccine for this strain.
A UK-Oxford vaccine candidate has begun Phase I testing in healthy volunteers to assess safety and immune response. The work leverages the same technology as the Oxford–AstraZeneca Covid jab. Trials are planned in Africa with regional partners as the outbreak continues in the Democratic Republic of Congo.
Two articles report on the Congo’s Ebola response amid ongoing unrest. Health workers warn that strikes and mob attacks are complicating response efforts as the outbreak continues to expand, with thousands of cases and hundreds of deaths across Ituri province.
Uganda and Africa CDC have formally urged the United States to remove travel restrictions tied to the Ebola outbreak. Uganda reports no new cases since July 16, with the last patient discharged, while the DRC faces a worsening Bundibugyo outbreak. Regional partners warn that border controls complicate trade and health work, as WHO warns the outbreak could be larger than detected.
The Bundibugyo-strain Ebola outbreak in the Democratic Republic of the Congo has reached over 4,000 confirmed cases with about 1,900 deaths, and is progressing at an unprecedented rate. Health workers face unpaid wages, security threats and misinformation while WHO and Africa CDC coordinate trials and vaccination efforts amid a volatile security situation.
The Democratic Republic of Congo’s Bundibugyo-variant Ebola outbreak has reached 4,945 confirmed cases and at least 2,325 deaths. The outbreak, the largest in the country’s history, is expanding rapidly with many cases detected late, and care access remains severely limited. Global health authorities are evaluating experimental options while vaccines and treatments remain limited.
The DRC has received an initial 16,250 doses of the Ervebo vaccine from a 70,000-dose allocation; 20,000 doses will enter a Phase III trial and 50,000 are for frontline health workers. CEPI has awarded up to $16.5m to Minapharm to advance a Bundibugyo-specific vaccine into early human trials. Uganda has received MBP134 antibody vials for immediate use if cases appear.
The Democratic Republic of Congo has experienced its deadliest and fastest-growing Ebola outbreak since mid‑May, with more than 5,600 confirmed cases and about 2,700 deaths across six provinces by late August 2026. The UN warns infections are rising faster than the response, funding is running short and frontline workers face attacks and heavy losses.
The Democratic Republic of the Congo faces the largest Ebola outbreak on record, with thousands of confirmed cases and deaths. Trust deficits and misinformation challenge responders, but community-led efforts are driving tracing, care, and safe burials. Frontline workers report stress and delayed pay, while aid demands rise as the outbreak accelerates.
The Democratic Republic of Congo has seen thousands of Ebola cases across six eastern provinces as the Bundibugyo strain spreads rapidly. Health workers are receiving Ervebo vaccination under compassionate-use rules, while the outbreak overwhells response efforts amid insecurity, displacement, and attacks on medical teams. WHO warns the outbreak may surpass West Africa’s deadliest period.